About Metrodora Institute
The mission of the Metrodora Institute is to advance care and accelerate cures for neuroimmune axis disorders. We have created the first integrated multidisciplinary clinic in the nation dedicated to treating these conditions. We have also built an innovation hub to collaborate with leading industry and academic partners to accelerate scientific discoveries and develop technologies that will lead to transformative breakthroughs in therapeutics and cures for people living with neuroimmune axis disorders.
The Metrodora model is truly a revolution in health care.
A Vision for a New Kind of Healthcare
As clinicians and researchers, we are acutely aware of the impact that neuroimmune axis disorders have on patients and the healthcare system. Metrodora Institute was designed to improve the landscape of healthcare for both patients and providers. We have created an objective, results-driven, comprehensive, and dynamic model of care that is responsive to patient needs. We have also built a system where providers have clinical support and access to state-of-the-art equipment and resources to practice the collaborative medicine required to treat these complex conditions.Learn more about the Metrodora patient experience
A Vision for a New Kind of Research
Neuroimmune axis disorders impact hundreds of millions of individuals worldwide. There is an urgent need to develop new diagnostic tools, therapeutics, and cures that will drive better care for these conditions. At the heart of our research strategy is the first high-density biobank and data repository focused on neuroimmune axis disorders. This resource allows us to collaborate, instead of competing, with leading scientists and engineers to make novel research insights and rapidly translate findings into the clinic to optimize patient care.Learn more about our unique research model
Our founders are world-renowned physicians, scientists, and tech leaders. Their combined expertise and experience position Metrodora Institute as a world leader in the space of neuroimmune axis disorders.
Laura A. Pace, MD, PhD
Chief Executive Officer and Co-Founder Metrodora InstituteRead Bio
James Hemp, PhD
Chief Scientific Officer and Co-Founder Metrodora InstituteRead Bio
President and Co-Founder Metrodora FoundationRead Bio